Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 97
Filter
Add more filters










Publication year range
1.
Oncogene ; 31(44): 4698-708, 2012 11 01.
Article in English | MEDLINE | ID: mdl-22249262

ABSTRACT

The Notch1-mediated signaling pathway has a central role in the maintenance of neural stem cells and contributes to growth and progression of glioblastomas, the most frequent malignant brain tumors in adults. Here, we demonstrate that the Notch1 receptor promotes survival of glioblastoma cells by regulation of the anti-apoptotic Mcl-1 protein. Notch1-dependent regulation of Mcl-1 occurs cell type dependent at a transcriptional or post-translational level and is mediated by the induction of epidermal growth factor receptor (EGFR). Inhibition of the Notch1 pathway overcomes apoptosis resistance and sensitizes glioblastoma cells to apoptosis induced by ionizing radiation, the death ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) or the Bcl-2/Bcl-XL inhibitor ABT-737. In conclusion, targeting Notch1 might represent a promising novel strategy in the treatment of glioblastomas.


Subject(s)
ErbB Receptors/metabolism , Glioblastoma/genetics , Glioblastoma/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Receptor, Notch1/metabolism , Signal Transduction , Apoptosis/genetics , Cell Line, Tumor , Cell Proliferation , Cell Survival/genetics , Drug Resistance, Neoplasm/genetics , Gene Expression Regulation, Neoplastic , Gene Silencing , Humans , Myeloid Cell Leukemia Sequence 1 Protein , Proto-Oncogene Proteins c-raf/metabolism , RNA Processing, Post-Transcriptional , Receptor, Notch1/genetics , Transcription, Genetic
2.
Sex Dev ; 3(5): 264-72, 2009.
Article in English | MEDLINE | ID: mdl-19851056

ABSTRACT

In mammals, insulin and insulin-like growth factors (IGFs: IGF1 and IGF2) act through 2 structurally related receptors, the insulin receptor (INSR) and the type 1 IGF receptor (IGF1R), both of which are expressed in developing oocytes. IGF1 plays an important role in female reproduction, and female Igf1 knockout mice fail to ovulate and are infertile. On the other hand, little is known about the in vivo role of the insulin signaling pathway in oocytes during follicular development, although exposure to insulin or IGF1 in vitro improves oocyte maturation. To further address the significance of insulin/IGF signaling, we used conditional mutant mice and ablated the function of the genes encoding INSR, IGF1R, or both receptors specifically in developing mouse oocytes. Our genetic evidence showed unexpectedly that the female reproductive functions are not affected when Insr, Igf1r or both Insr;Igf1r are ablated in oocytes, as the female mice are fertile and exhibit normal estrous cyclicity, oocyte development and maturation, parturition frequency, and litter size. In view of these novel observations indicating that the insulin/IGF signaling is not essential in oocytes, the IGF1-dependent female fertility is re-evaluated and discussed.


Subject(s)
Cell Differentiation , Oocytes/cytology , Oogenesis/genetics , Receptor, IGF Type 1/metabolism , Receptor, Insulin/metabolism , Animals , Blotting, Western , Female , Immunohistochemistry , Mice , Mice, Knockout , Receptor, IGF Type 1/genetics , Receptor, Insulin/genetics , Reverse Transcriptase Polymerase Chain Reaction
3.
Article in English | MEDLINE | ID: mdl-19022744

ABSTRACT

Malignant astrocytomas are highly invasive brain tumors that portend poor prognosis and dismal survival. Mouse models that genetically resemble the human malignancy provide insight into the nature and pathogenesis of these cancers. We previously reported tumor suppressor mouse models based on conditional inactivation of human astrocytoma-relevant genes p53, Nf1, and Pten. These mice develop, with full penetrance, varying grades of astrocytic malignancy that recapitulate the human condition histologically and molecularly. Our studies indicate a central role for neural stem cells and stem-cell-like cancer cells in tumor initiation and progression. These mouse models thus represent powerful tools for investigating various aspects of tumor development that otherwise cannot be explored in humans. Further studies will provide a better understanding of the biology of these tumors and will hopefully pave the way for more effective therapeutic approaches for these devastating diseases.


Subject(s)
Astrocytoma/pathology , Brain Neoplasms/pathology , Neoplastic Stem Cells/pathology , Neurons/pathology , Animals , Astrocytoma/etiology , Astrocytoma/genetics , Brain Neoplasms/etiology , Brain Neoplasms/genetics , Disease Models, Animal , Genes, Tumor Suppressor , Humans , Mice , Models, Neurological , Mutation
4.
Oncogene ; 26(32): 4609-16, 2007 Jul 12.
Article in English | MEDLINE | ID: mdl-17297459

ABSTRACT

The human disease von Recklinghausen's neurofibromatosis (Nf1) is one of the most common genetic disorders. It is caused by mutations in the NF1 tumor suppressor gene, which encodes a GTPase activating protein (GAP) that negatively regulates p21-RAS signaling. Dermal and plexiform neurofibromas as well as malignant peripheral nerve sheath tumors and other malignant tumors, are significant complications in Nf1. Neurofibromas are complex tumors and composed mainly of abnormal local cells including Schwann cells, endothelial cells, fibroblasts and additionally a large number of infiltrating inflammatory mast cells. Recent work has indicated a role for the microenvironment in plexiform neurofibroma genesis. The emerging evidence points to mast cells as crucial contributors to neurofibroma tumorigenesis. Therefore, further understanding of the molecular interactions between Schwann cells and their environment will provide tools to develop new therapies aimed at delaying or preventing tumor formation in Nf1 patients.


Subject(s)
Genes, Neurofibromatosis 1 , Mast Cells/physiology , Neurofibromatosis 1/etiology , Neurofibromin 1/physiology , Animals , Humans , Mast Cells/enzymology , Mice , Neurofibromatosis 1/genetics , Neurofibromatosis 1/therapy , Neurofibromin 1/genetics
5.
Cell Mol Life Sci ; 64(5): 522-32, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17192812

ABSTRACT

The Trk family of neurotrophin receptors plays essential roles in cell fate specification, survival, growth, and differentiation. Their expression patterns are complex and dynamically regulated under many physiological and pathological conditions. However, the molecular mechanisms that control their tissue-specific expression are largely unknown. In this report, we review current knowledge about the transcriptional regulation of Trk receptors.


Subject(s)
Gene Expression Regulation , Receptor, trkA/genetics , Transcription, Genetic , Animals , Enhancer Elements, Genetic , Humans , Models, Animal , Receptor, trkB/genetics
6.
Cell Death Differ ; 12(12): 1601-12, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15947791

ABSTRACT

Neural stem cells in the mammalian brain persist and are functional well into adulthood. There is, however, little insight into mechanisms that control adult neural stem cell survival. Mice deficient in the proapoptotic molecule Bax exhibit increased numbers of multipotent progenitor cells in the adult subventricular zone. In vitro, these progenitors behave as neural stem cells and utilize Bax and caspase activation to direct cell death. We demonstrate that the predominate mechanism underlying caspase and Bax-mediated adult neural stem cell death lies in the modulation of calcium flux through interaction with the IP3 receptor.


Subject(s)
Calcium/metabolism , Caspase 3/metabolism , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Multipotent Stem Cells/cytology , Neurons/cytology , bcl-2-Associated X Protein/metabolism , Animals , Cell Death/physiology , Cells, Cultured , Enzyme Activation , Lateral Ventricles/cytology , Mice , Mice, Knockout , Multipotent Stem Cells/physiology , Neurons/physiology , bcl-2-Associated X Protein/genetics
7.
Article in English | MEDLINE | ID: mdl-16869751

ABSTRACT

Von Recklinghausen's neurofibromatosis is a dominantly inherited cancer syndrome. Its gene encodes neurofibromin, a protein with ras GTPase-activating function (rasGAP) and, therefore, all NF1-associated pathology is thought to originate from selective deregulation of the ras pathway. We have constructed a variety of mouse models for NF1 that permit recapitulation of the most common tumors seen in patients. In addition, these mouse models offer insights into tumor origin and into paracrine interactions. Given the molecular and pathological fidelity of the mouse tumors to the human counterparts, it is hoped that these mouse strains will serve as effective tools for therapeutic discovery.


Subject(s)
Neurofibromatosis 1/therapy , Animals , Astrocytoma/etiology , Astrocytoma/genetics , Central Nervous System Neoplasms/etiology , Central Nervous System Neoplasms/genetics , Disease Models, Animal , Genes, Neurofibromatosis 1 , Heterozygote , Humans , Loss of Heterozygosity , Mast Cells/physiology , Mice , Mice, Mutant Strains , Neurofibromatosis 1/etiology , Neurofibromatosis 1/genetics , Neurofibromatosis 1/physiopathology , Schwann Cells/physiology , Signal Transduction , ras Proteins/physiology
8.
Neuroscience ; 126(4): 859-69, 2004.
Article in English | MEDLINE | ID: mdl-15207321

ABSTRACT

Brain-derived neurotrophic factor (BDNF) and its cognate receptor tyrosine kinase B (TrkB) play important roles in regulating survival, structure, and function of CNS neurons. One method of studying the functions of these molecules has utilized in vitro hippocampal slice preparations. An important caveat to using slices, however, is that slice preparation itself might alter the expression of BDNF, thereby confounding experimental results. To address this concern, BDNF immunoreactivity was examined in rodent slices using two different methods of slice preparation. Rapid and anatomically selective regulation of BDNF content followed slice preparation using both methodologies; however, different patterns of altered BDNF immunoreactivity were observed. First, in cultured slices, BDNF content decreased in the dentate molecular layer and increased in the CA3 pyramidal cell layer and the mossy fiber pathway of the hippocampus after 30 min. Furthermore, an initially "punctate" pattern of BDNF labeling observed in the mossy fiber pathway of control sections changed to homogenous labeling of the pathway in vitro. In contrast to these findings, slices prepared as for acute slice physiology exhibited no change in BDNF content in the molecular layer and mossy fiber pathway 30 min after slicing, but exhibited significant increases in the dentate granule and CA3 pyramidal cell layers. These findings demonstrate that BDNF protein content is altered following slice preparation, that different methods of slice preparation produce different patterns of BDNF regulation, and raise the possibility that BDNF release and TrkB activation may also be regulated. These consequences of hippocampal slice preparation may confound analyses of exogenous or endogenous BDNF on hippocampal neuronal structure or function.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Hippocampus/metabolism , Analysis of Variance , Animals , Animals, Newborn , Brain-Derived Neurotrophic Factor/deficiency , Brain-Derived Neurotrophic Factor/genetics , Cell Count/methods , Hippocampus/anatomy & histology , Immunohistochemistry/methods , Male , Mice , Mice, Knockout , Microscopy, Confocal/methods , Organ Culture Techniques , Rats , Rats, Sprague-Dawley , Synapsins/genetics , Synapsins/metabolism , Time Factors
9.
Neuroscience ; 122(1): 229-35, 2003.
Article in English | MEDLINE | ID: mdl-14596863

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF), neurturin (NTN) and their receptors (GFRalpha1, GFRalpha2 and Ret) play an important role in the survival of neurons in the central and peripheral nervous system. For example, GDNF as well as other trophic factors promotes photoreceptor survival during retinal degeneration. Recent studies have proposed that part of neurotophic rescue of photoreceptors may be indirect, mediated by interaction of the neurotrophic factors with other cell types, that in turn release secondary factors that act directly on photoreceptors. In the present study, we examined the GDNF receptor expression in control and light-damaged retina, and found that GFRalpha2 protein is upregulated in retina-specific Müller glial cells during photoreceptor degeneration. We also examined the effect of GDNF or NTN on cultured Müller cells. Exogenous GDNF increased brain-derived neurotrophic factor, basic fibroblast growth factor and GDNF, but not NTN mRNA production. On the other hand, NTN increased NTN, but not GDNF mRNA production in cultured Müller cells. These observations suggest that GDNF, NTN and their receptors are involved in the regulation of trophic factor production in retinal glial cells, and that functional glia-neuron network may utilize GDNF family for the protection of neural cells during retinal degeneration.


Subject(s)
Light , Nerve Growth Factors/metabolism , Neuroglia/metabolism , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Retinal Degeneration/metabolism , Animals , Cell Culture Techniques , Gene Expression Regulation , Glial Cell Line-Derived Neurotrophic Factor , Glial Cell Line-Derived Neurotrophic Factor Receptors , Immunohistochemistry , Nerve Growth Factors/drug effects , Nerve Growth Factors/pharmacology , Neuroglia/drug effects , Neurturin , Proto-Oncogene Proteins c-ret , Rats , Rats, Wistar , Retina/pathology , Reverse Transcriptase Polymerase Chain Reaction , Up-Regulation
10.
Neuroscience ; 117(4): 847-58, 2003.
Article in English | MEDLINE | ID: mdl-12654337

ABSTRACT

The mammalian trkB locus undergoes alternative splicing to produce two different types of brain-derived neurotrophic factor receptors. The first type is the full-length receptor tyrosine kinase (TrkB(Tk+); the second type is a truncated receptor lacking the intracellular tyrosine kinase domain (TrkB(Tk-)). To investigate the function of both types of TrkB receptor in vivo, we have generated knockout mice lacking all isoforms of the TrkB receptor (trkB-/-) and compared sensory neuron survival in these mice to that in the previously described TrkB kinase domain knockout mice (trkB(k)-/-). We observed that the presence of truncated TrkB receptors in trkB(k)-/- mice results in more severe sensory neuron losses. Increased neuron losses associated with the presence of truncated TrkB were most severe in regions where neuron survival is most dependent on brain-derived neurotrophic factor and neurotrophin-3. Our data suggest that truncated TrkB receptors negatively influence neuron survival by interfering with the function of catalytic TrkB receptors.


Subject(s)
Cell Differentiation/genetics , Cell Survival/genetics , Ganglia, Sensory/growth & development , Ganglia, Sensory/metabolism , Neurons, Afferent/metabolism , Receptor, trkB/deficiency , Animals , Animals, Newborn , Carbocyanines , Catalytic Domain/genetics , Cell Death/genetics , Cochlea/growth & development , Cochlea/innervation , Cochlea/metabolism , Ganglia, Sensory/cytology , Mice , Mice, Knockout , Models, Biological , Nerve Growth Factors/metabolism , Neurons, Afferent/cytology , Protein Isoforms/genetics , Receptor, trkB/genetics , Receptor, trkC/genetics , Receptor, trkC/metabolism , Signal Transduction/genetics , Spiral Ganglion/cytology , Spiral Ganglion/growth & development , Spiral Ganglion/metabolism , Survival Rate , Up-Regulation/genetics
11.
Hum Mol Genet ; 10(26): 3009-16, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11751683

ABSTRACT

Individuals with the neurofibromatosis 1 (NF1) tumor predisposition syndrome develop low-grade pilocytic astrocytomas at an increased frequency. Previously, we demonstrated that astrocytes from mice heterozygous for a targeted mutation in the Nf1 gene (Nf1+/- astrocytes) exhibit a cell autonomous growth advantage associated with increased RAS pathway activation. In this report, we extend our initial characterization of the effect of reduced Nf1 gene expression on astrocyte function by demonstrating that Nf1+/- astrocytes exhibit decreased cell attachment, actin cytoskeletal abnormalities during the initial phases of cell spreading, and increased cell motility. Whereas these cytoskeletal abnormalities were also observed in Nf1-/- astrocytes, astrocytes expressing a constitutively active RAS molecule showed increased cell motility and abnormal actin cytoskeleton organization during cell spreading, but exhibited normal cell attachment. Based on ongoing gene expression profiling experiments on human astrocytoma tumors, we demonstrate increased expression of two proteins implicated in cell attachment, spreading and motility (GAP43 and T-cadherin) in Nf1+/- and Nf1-/- astrocytes. These results support the emerging notion that tumor suppressor gene heterozygosity results in abnormalities in cell function that may contribute to the pathogenesis of non-tumor phenotypes in NF1.


Subject(s)
Astrocytes/pathology , Heterozygote , Neurofibromatosis 1/genetics , Animals , Cadherins/metabolism , Cell Adhesion/genetics , Cell Movement/genetics , Cell Movement/physiology , Cytoskeleton/metabolism , Fibronectins/metabolism , GAP-43 Protein/metabolism , Immunohistochemistry , Mice , Mice, Knockout , Mice, Transgenic , Neurofibromatosis 1/physiopathology , Neurofibromin 1/metabolism
12.
J Neurosci Res ; 66(3): 317-26, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11746349

ABSTRACT

The persistence of neural stem cells into adulthood has been an area of intense investigation in recent years. There is limited knowledge about how an acquired brain injury might affect the ability of neural precursor cells to proliferate and repopulate injured areas. In the present study we utilize a controlled cortical impact model of traumatic brain injury in adult mice and subsequent BrdU labeling to demonstrate that there is significant proliferation of neural precursors in response to traumatic brain injury in areas both proximal and distal to the injury site. The fate of the proximal proliferation is almost exclusively astrocytic at 60-days post injury and demonstrates that newly generated cells make up much of the astrogliotic scar. Moreover, in areas more distal from the injury site, neurogenesis occurs within the granular layer of the dentate gyrus at a level more than five-fold greater than in controls. These data demonstrate that neural proliferation plays key roles in the remodeling that occurs after traumatic brain injury and suggests a mechanism as to how functional recovery after traumatic brain injuries continues to occur long after the injury itself.


Subject(s)
Astrocytes/metabolism , Brain Injuries/physiopathology , Cell Division/physiology , Gliosis/physiopathology , Nerve Regeneration/physiology , Nerve Tissue Proteins , Neurons/metabolism , Stem Cells/metabolism , Animals , Astrocytes/cytology , Bromodeoxyuridine/metabolism , Calbindins , Cerebral Cortex/cytology , Cerebral Cortex/injuries , Cerebral Cortex/metabolism , Dentate Gyrus/cytology , Dentate Gyrus/metabolism , Disease Models, Animal , Glial Fibrillary Acidic Protein/metabolism , Gliosis/etiology , Immunohistochemistry , Intermediate Filament Proteins/metabolism , Male , Mice , Mice, Inbred Strains , Nestin , Neuronal Plasticity/physiology , Neurons/cytology , Recovery of Function/physiology , S100 Calcium Binding Protein G/metabolism , S100 Proteins/metabolism , Stem Cells/cytology , Up-Regulation/physiology
13.
Neuroscience ; 106(2): 263-74, 2001.
Article in English | MEDLINE | ID: mdl-11566499

ABSTRACT

Apoptotic protease-activating factor-1 (Apaf-1), dATP, and procaspase-9 form a multimeric complex that triggers programmed cell death through the activation of caspases upon release of cytochrome c from the mitochondria into the cytosol. Although cell death pathways exist that can bypass the requirement for cytochrome c release and caspase activation, several gene knockout studies have shown that the cytochrome c-mediated apoptotic pathway is critical for neural development. Specifically, the number of neuronal progenitor cells is abnormally increased in Apaf-1-, caspase-9-, caspase-3-deficient mice. However, the role of the cytochrome c cell death pathway for apoptosis of postmitotic, differentiated neurons in the developing brain has not been investigated in vivo. In this study we investigated embryonic neuronal cell death caused by trophic factor deprivation or lack of neurotransmitter release by analyzing Apaf-1/tyrosine kinase receptor A (TrkA) and Apaf-1/Munc-18 double mutant mice. Histological analysis of the double mutants' brains (including cell counting and terminal (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) staining) reveals that neuronal cell death caused by these stimuli can proceed independent of Apaf-1. We propose that a switch between apoptotic programs (and their respective proteins) characterizes the transition of a neuronal precursor cell from the progenitor pool to the postmitotic population of differentiated neurons.


Subject(s)
Apoptosis/genetics , Nerve Growth Factors/metabolism , Nerve Tissue Proteins , Nervous System/embryology , Neurons/metabolism , Neurotransmitter Agents/metabolism , Proteins/metabolism , Stem Cells/metabolism , Vesicular Transport Proteins , Animals , Apoptotic Protease-Activating Factor 1 , Caspases/metabolism , Cell Cycle/genetics , Cell Differentiation/genetics , Cytochrome c Group/metabolism , Ganglia, Sensory/cytology , Ganglia, Sensory/embryology , Ganglia, Sensory/metabolism , Mice , Mice, Knockout , Munc18 Proteins , Nervous System/cytology , Nervous System/metabolism , Neurons/cytology , Proteins/genetics , Receptor, trkA/deficiency , Receptor, trkA/genetics , Signal Transduction/genetics , Stem Cells/cytology
14.
J Neurochem ; 78(3): 631-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11483666

ABSTRACT

We have studied the role of MAP kinase pathways in neuronal nitric oxide synthase (nNOS) induction during the differentiation of PC12 cells. In nerve growth factor (NGF)-treated PC12 cells, we find nNOS induced at RNA and protein levels, resulting in increased NOS activity. We note that neither nNOS mRNA, nNOS protein nor NOS activity is induced by NGF treatment in cells that have been infected with a dominant negative Ras adenovirus. We have also used drugs that block MAP kinase pathways and assessed their ability to inhibit nNOS induction. Even though U0126 and PD98059 are both MEK inhibitors, we find that U0126, but not PD98059, blocks induction of nNOS protein and NOS activity in NGF-treated PC12 cells. Also, the p38 kinase inhibitor, SB203580, does not block nNOS induction in our clone of PC12 cells. Since the JNK pathway is not activated in NGF-treated PC12 cells, we conclude that the Ras-ERK pathway and not the p38 or JNK pathway is required for nNOS induction in NGF-treated PC12 cells. We find that U0126 is much more effective than PD98059 in blocking the Ras-ERK pathway, thereby explaining the discrepancy in nNOS inhibition. We conclude that the Ras-ERK pathway is required for nNOS induction.


Subject(s)
Mitogen-Activated Protein Kinases/metabolism , Neurons/cytology , Neurons/enzymology , Nitric Oxide Synthase/biosynthesis , ras Proteins/metabolism , Animals , Butadienes/pharmacology , Cell Differentiation/drug effects , Culture Media, Serum-Free , Enzyme Induction , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Genetic Vectors/metabolism , Imidazoles/pharmacology , Immunoblotting , Nerve Growth Factor/pharmacology , Neurites/drug effects , Neurites/metabolism , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type I , Nitriles/pharmacology , PC12 Cells , Pyridines/pharmacology , Rats
15.
Exp Biol Med (Maywood) ; 226(8): 766-75, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11520943

ABSTRACT

Both nerve growth factor (NGF) and neurotrophin-3 (NT-3) are necessary for the survival of embryonic sympathetic neurons in vivo. All-trans retinoic acid (atRA) has been shown to promote neurite outgrowth and long-term survival of chick embryonic sympathetic neurons cultured in the presence of NGF. The present study shows that atRA can also potentiate the survival and neurite outgrowth-promoting activities of NT-3. This was accomplished by enhancing the survival of existing neurons, as cell proliferation was unaffected by exposure to atRA. atRA also enhanced neurite outgrowth of the NT-3-treated cells; however, the neurites appeared thicker and less branched than cells treated with atRA in combination with NGF. Using a quantitative PCR assay, trkA and p75(NTR) mRNAs, but not trkC mRNA, were increased ( approximately 1.5- to 2-fold) after 72 and 48 hr of exposure of the cultures to atRA, respectively. The atRA-induced increase in trkA mRNA may play a role in the enhanced survival of neurons cultured in the presence of either NGF or NT-3, as both neurotrophins have been shown to signal through this receptor. The time course of these mRNA changes would indicate that atRA does not regulate the neurotrophin receptor mRNA directly, rather, intervening gene transcription is required. Thus, during development, atRA may play a role in fine-tuning embryonic responsiveness to both NT-3 and NGF.


Subject(s)
Neurons/cytology , Neurons/metabolism , Neurotrophin 3/therapeutic use , Tretinoin/therapeutic use , Animals , Cell Division/drug effects , Cell Survival/drug effects , Chick Embryo , Drug Interactions , Keratolytic Agents/therapeutic use , Nerve Growth Factor/pharmacology , Polymerase Chain Reaction/methods , RNA, Messenger/metabolism , Receptor, Nerve Growth Factor , Receptor, trkA/biosynthesis , Receptor, trkC/biosynthesis , Receptors, Nerve Growth Factor/biosynthesis , Time Factors
16.
Mol Cell Biol ; 21(16): 5624-30, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11463843

ABSTRACT

Receptors of the insulin/insulinlike growth factor (IGF) family have been implicated in the regulation of pancreatic beta-cell growth and insulin secretion. The insulin receptor-related receptor (IRR) is an orphan receptor of the insulin receptor gene (Ir) subfamily. It is expressed at considerably higher levels in beta cells than either insulin or IGF-1 receptors, and it has been shown to engage in heterodimer formation with insulin or IGF-1 receptors. To address whether IRR plays a physiologic role in beta-cell development and regulation of insulin secretion, we have characterized mice lacking IRR and generated a combined knockout of Ir and Irr. We report that islet morphology, beta-cell mass, and secretory function are not affected in IRR-deficient mice. Moreover, lack of IRR does not impair compensatory beta-cell hyperplasia in insulin-resistant Ir(+/-) mice, nor does it affect beta-cell development and function in Ir(-/-) mice. We conclude that glucose-stimulated insulin secretion and embryonic beta-cell development occur normally in mice lacking Irr.


Subject(s)
Receptor, Insulin/physiology , Animals , Insulin/physiology , Insulin-Like Growth Factor I/physiology , Islets of Langerhans/embryology , Islets of Langerhans/physiology , Mice , Mice, Knockout , Receptor, IGF Type 1/physiology
17.
J Urol ; 165(5): 1673-5, 2001 May.
Article in English | MEDLINE | ID: mdl-11342953

ABSTRACT

PURPOSE: Testicular descent is controlled by 2 morphological and hormonal steps. Transabdominal testicular descent is mediated by gubernacular swelling and regression of the cranial suspensory ligament. Müllerian inhibiting substance (MIS) has been proposed to stimulate the swelling but this remains controversial. Recently, a mouse mutant for Leydig insulin-like hormone (Insl3) was found to have undescended testis and deficient gubernaculum. We examine the testicular position of Insl3 mutant mice and the development of gubernacula. MATERIALS AND METHODS: Mice with Insl3 homozygotes (-/-), heterozygotes (+/-) and wild-types (+/+) were examined at embryonic day 16.5 and birth. Macroscopic dissections and measurements of the testicular position, as well as microscopic analysis (hematoxylin and eosin, and Masson's trichrome) were performed. RESULTS: Of the mice 11 Insl3 homozygote males had significantly impaired testicular descent at embryonic day 16.5 and birth (p <0.01), and the cord was thin and elongated, while 14 heterozygotes and 7 wild-types had normal testicular descent. Microscopically, the gubernaculum of Insl3 homozygotes was small with some muscle development but no central core of mesenchyme at embryonic day 16.5. On the other hand, heterozygotes and wild-types had normal gubernacular development with a swelling reaction. CONCLUSIONS: Insl3 mutants show feminized gubernaculum with deficient mesenchymal core. Insl3 appears to have some role in the gubernacular swelling reaction in mice.


Subject(s)
Hormones/physiology , Ligaments/embryology , Ligaments/physiology , Proteins/physiology , Testis/embryology , Animals , Heterozygote , Homozygote , Hormones/genetics , Insulin , Male , Mice , Mice, Mutant Strains , Mutation , Proteins/genetics
18.
Dev Biol ; 234(1): 80-92, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11356021

ABSTRACT

Neurons of the vertebrate olfactory epithelium (OE) regenerate continuously throughout life. The capacity of these neurons to regenerate and make new and precise synaptic connections in the olfactory bulb provides a useful model to study factors that may control or mediate neuronal regeneration. Expression and in vitro studies have suggested potential roles for the neurotrophins in the olfactory system. To directly examine whether neurotrophins are required for olfactory neuron development, we characterized in vivo the role of the neurotrophins in the primary olfactory system. For this, we generated mutant mice for TrkA, TrkB, TrkC, and also for BDNF and NT3 together with P2-IRES-tau-LacZ trangenic mice. Histochemical staining for beta-galactosidase at birth allowed in vivo analysis of the P2 subpopulation of olfactory neurons as well as their projections to the olfactory bulb. Our data indicate that Trk signaling is not required for normal embryonic development of the olfactory system.


Subject(s)
Nerve Growth Factors/metabolism , Olfactory Bulb/embryology , Olfactory Mucosa/embryology , Olfactory Nerve/embryology , Olfactory Pathways/embryology , Receptors, Nerve Growth Factor/metabolism , Animals , Mice , Mice, Knockout , Nerve Regeneration , Neurons/metabolism , Olfactory Bulb/cytology , Olfactory Mucosa/cytology , Olfactory Nerve/cytology , Olfactory Pathways/cytology
19.
Genes Dev ; 15(7): 859-76, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-11297510

ABSTRACT

Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder that affects growth properties of neural-crest-derived cell populations. In addition, approximately one-half of NF1 patients exhibit learning disabilities. To characterize NF1 function both in vitro and in vivo, we circumvent the embryonic lethality of NF1 null mouse embryos by generating a conditional mutation in the NF1 gene using Cre/loxP technology. Introduction of a Synapsin I promoter driven Cre transgenic mouse strain into the conditional NF1 background has ablated NF1 function in most differentiated neuronal populations. These mice have abnormal development of the cerebral cortex, which suggests that NF1 has an indispensable role in this aspect of CNS development. Furthermore, although they are tumor free, these mice display extensive astrogliosis in the absence of conspicuous neurodegeneration or microgliosis. These results indicate that NF1-deficient neurons are capable of inducing reactive astrogliosis via a non-cell autonomous mechanism.


Subject(s)
Cerebral Cortex/abnormalities , Disease Models, Animal , Gliosis/metabolism , Nerve Tissue Proteins/physiology , Viral Proteins , Alleles , Animals , Cell Transformation, Neoplastic/genetics , Cells, Cultured , Cerebral Cortex/embryology , Ganglia, Spinal/pathology , Gene Expression Regulation, Developmental , Genes, Neurofibromatosis 1 , Genes, Reporter , Genes, Synthetic , Genetic Vectors/genetics , Integrases/genetics , Integrases/physiology , Lac Operon , Learning Disabilities/genetics , MAP Kinase Signaling System/genetics , Mice , Mice, Knockout , Mice, Neurologic Mutants , Mice, Transgenic , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Neurofibromin 1 , Neurons/metabolism , Promoter Regions, Genetic , Proto-Oncogene Proteins p21(ras)/physiology , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/physiology , Signal Transduction , Synapsins/genetics , p120 GTPase Activating Protein/genetics , p120 GTPase Activating Protein/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...